Information
-
Trademark
-
98850900
-
International Classifications
-
Filing Date
November 13, 2024
12 months ago
-
Transaction Date
July 11, 2025
4 months ago
-
Status Date
March 30, 2025
7 months ago
-
Location Date
March 30, 2025
7 months ago
-
Status Code
641
-
Current Location
TMO LAW OFFICE 111
Employee Name
QUEEN, ESTHER
-
Attorney Docket Number
140679600968
Attorney Name
Kristen S. Ruisi
Law Office Assigned Location Code
M20
-
Owners
Mark Drawing Code
3
Mark Identification
BEONE
Case File Statements
- GS0401: Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
- DM0000: The mark consists of the word BEONE in stylized form to the right of a shaded square with a stylized square and a star in the center of the stylized square.
- GS0051: Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
- PM0001: BE ONE; BE 1
- CC0000: Color is not claimed as a feature of the mark.
- GS0441: Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice
- GS0421: Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design
Case File Event Statements
-
11/13/2024 - 12 months ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
3/30/2025 - 7 months ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
3/30/2025 - 7 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
3/30/2025 - 7 months ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/30/2025 - 7 months ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/30/2025 - 7 months ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
3/30/2025 - 7 months ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/27/2025 - 4 months ago
9 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Type: XELG
-
7/9/2025 - 4 months ago
10 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Type: ASCK
-
7/10/2025 - 4 months ago
11 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Type: ASGN
-
6/27/2025 - 4 months ago
8 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Type: XELR